Key facts
- This page summarizes ARCH Venture Partners X, LLC's Form 4 filing for Verve Therapeutics, Inc. (VERV).
- 6 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 23 Jun 2021, 16:29.
ARCH Venture Partners X, LLC - 21 Jun 2021 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- VERV
- Reported as of
- 21 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Jun 2021, 16:29:06 UTC
- Next SEC filing
- 15 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ ARCH Venture Fund X, L.P., By: ARCH Venture Partners X, L.P., its General Partner, By: ARCH Venture Partners X, LLC, its General Partner, By: Mark McDonnell, attorney in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
ARCH Venture Partners X, LLC filed Form 4 for Verve Therapeutics, Inc. (VERV) on 23 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VERV
transaction
Common Stock, par value $0.001
Conversion of derivative security
- Transaction value
- Shares
- +1,254,404
- Change %
- Price
- Shares after
- 1,254,404
- Date
- 21 Jun 2021
- Ownership
- ARCH Venture Fund X, L.P.
- Footnotes
- F1, F3, F4
VERV
transaction
Common Stock, par value $0.001
Conversion of derivative security
- Transaction value
- Shares
- +1,254,405
- Change %
- Price
- Shares after
- 1,254,405
- Date
- 21 Jun 2021
- Ownership
- ARCH Venture Fund X Overage, L.P.
- Footnotes
- F2, F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VERV
transaction
Derivative
Series A Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -7,107,024
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jun 2021
- Ownership
- See Footnotes
- Underlying class
- Common Stock
- Underlying amount
- 767,538
- Exercise price
- Footnotes
- F1, F3, F4, F5
VERV
transaction
Derivative
Series A Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -7,107,023
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jun 2021
- Ownership
- See Footnotes
- Underlying class
- Common Stock
- Underlying amount
- 767,538
- Exercise price
- Footnotes
- F2, F3, F4, F5
VERV
transaction
Derivative
Series A-2 Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -4,508,144
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jun 2021
- Ownership
- See Footnotes
- Underlying class
- Common Stock
- Underlying amount
- 486,866
- Exercise price
- Footnotes
- F1, F3, F4, F5
VERV
transaction
Derivative
Series A-2 Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -4,508,146
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jun 2021
- Ownership
- See Footnotes
- Underlying class
- Common Stock
- Underlying amount
- 486,867
- Exercise price
- Footnotes
- F2, F3, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
ARCH Venture Partners X, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 5 footnotes
Footnote F1
Represents shares held directly by ARCH Venture Fund X, L.P. (ARCH X). ARCH Venture Partners X, L.P. (AVP X LP) is the sole general partner of ARCH X.
Footnote F2
Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage). ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage.
Footnote F3
ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP. Robert Nelsen, Keith Crandell, Kristina Burow and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X LP and AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, respectively, AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. AVP X LP, AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein.
Footnote F4
The shares of Issuer's Preferred Stock converted into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-9.2595 basis immediately prior to the consummation of Issuer's initial public offering.
Footnote F5
The expiration date is not relevant to the conversion of these securities.